Advertisement
Screener

ENTASIS THERAPEUTICS HOLDINGS INC. Share-based Payment Arrangement, Expense

ENTASIS THERAPEUTICS HOLDINGS INC. Share-based Payment Arrangement, Expense

ENTASIS THERAPEUTICS HOLDINGS INC. reported Share-based Payment Arrangement, Expense of $697.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-04-27.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-04-27

  • ENTASIS THERAPEUTICS HOLDINGS INC. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $697.00K, a 19.79% decline year-over-year.
  • ENTASIS THERAPEUTICS HOLDINGS INC. share-based payment arrangement, expense for the quarter ending 2021-12-31 was $1.35M, a 80.05% increase year-over-year.
  • ENTASIS THERAPEUTICS HOLDINGS INC. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $918.00K, a 38.25% increase year-over-year.
  • ENTASIS THERAPEUTICS HOLDINGS INC. share-based payment arrangement, expense for the quarter ending 2021-06-30 was $882.00K, a 17.60% increase year-over-year.
  • ENTASIS THERAPEUTICS HOLDINGS INC. share-based payment arrangement, expense for fiscal 2021 was $4.02M, a 36.33% increase from fiscal 2020.
  • ENTASIS THERAPEUTICS HOLDINGS INC. share-based payment arrangement, expense for fiscal 2020 was $2.95M, a 21.89% increase from fiscal 2019.
  • ENTASIS THERAPEUTICS HOLDINGS INC. share-based payment arrangement, expense for fiscal 2019 was $2.42M, a 101.58% increase from fiscal 2018.
  • ENTASIS THERAPEUTICS HOLDINGS INC. share-based payment arrangement, expense for fiscal 2018 was $1.20M, a 185.95% increase from fiscal 2017.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2022-03-31$697.00K
10-Q · filed 2022-04-27
$2.05M
derived: sum of 2 quarters · filed 2022-04-27
$2.97M
derived: sum of 3 quarters · filed 2022-04-27
$3.85M
derived: sum of 4 quarters · filed 2022-04-27
2021-12-31$1.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$2.27M
derived: sum of 2 quarters · filed 2022-03-03
$3.15M
derived: sum of 3 quarters · filed 2022-03-03
$4.02M
10-K · filed 2022-03-03
2021-09-30$918.00K
10-Q · filed 2021-11-04
$1.80M
derived: sum of 2 quarters · filed 2021-11-04
$2.67M
10-Q · filed 2021-11-04
$3.42M
derived: sum of 4 quarters · filed 2022-04-27
2021-06-30$882.00K
10-Q · filed 2021-08-12
$1.75M
10-Q · filed 2021-08-12
$2.50M
derived: sum of 3 quarters · filed 2022-04-27
$3.17M
derived: sum of 4 quarters · filed 2022-04-27
2021-03-31$869.00K
10-Q · filed 2022-04-27
$1.62M
derived: sum of 2 quarters · filed 2022-04-27
$2.29M
derived: sum of 3 quarters · filed 2022-04-27
$3.04M
derived: sum of 4 quarters · filed 2022-04-27
2020-12-31$752.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$1.42M
derived: sum of 2 quarters · filed 2022-03-03
$2.17M
derived: sum of 3 quarters · filed 2022-03-03
$2.95M
10-K · filed 2022-03-03
2020-09-30$664.00K
10-Q · filed 2021-11-04
$1.41M
derived: sum of 2 quarters · filed 2021-11-04
$2.20M
10-Q · filed 2021-11-04
$2.87M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$750.00K
10-Q · filed 2021-08-12
$1.53M
10-Q · filed 2021-08-12
$2.21M
derived: sum of 3 quarters · filed 2021-08-12
$2.78M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$785.00K
10-Q · filed 2021-05-05
$1.46M
derived: sum of 2 quarters · filed 2021-05-05
$2.03M
derived: sum of 3 quarters · filed 2021-05-05
$2.63M
derived: sum of 4 quarters · filed 2021-05-05
2019-12-31$673.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-30
$1.24M
derived: sum of 2 quarters · filed 2021-04-30
$1.84M
derived: sum of 3 quarters · filed 2021-04-30
$2.42M
10-K/A · filed 2021-04-30
2019-09-30$571.00K
10-Q · filed 2020-11-05
$1.17M
derived: sum of 2 quarters · filed 2020-11-05
$1.75M
10-Q · filed 2020-11-05
$2.14M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$599.00K
10-Q · filed 2020-08-06
$1.18M
10-Q · filed 2020-08-06
$1.57M
derived: sum of 3 quarters · filed 2020-08-06
$1.91M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$578.00K
10-Q · filed 2020-05-07
$973.00K
derived: sum of 2 quarters · filed 2020-05-07
$1.31M
derived: sum of 3 quarters · filed 2020-05-07
$1.58M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$395.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
$728.00K
derived: sum of 2 quarters · filed 2020-03-11
$1.00M
derived: sum of 3 quarters · filed 2020-03-11
$1.20M
10-K · filed 2020-03-11
2018-09-30$333.00K
10-Q · filed 2019-11-14
$606.00K
derived: sum of 2 quarters · filed 2019-11-14
$806.00K
10-Q · filed 2019-11-14
$957.00K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$273.00K
10-Q · filed 2019-08-12
$473.00K
10-Q · filed 2019-08-12
$624.00K
derived: sum of 3 quarters · filed 2019-08-12
$688.00K
derived: sum of 4 quarters · filed 2019-08-12
2018-03-31$200.00K
10-Q · filed 2019-05-14
$351.00K
derived: sum of 2 quarters · filed 2019-05-14
$415.00K
derived: sum of 3 quarters · filed 2019-05-14
2017-12-31$151.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$215.00K
derived: sum of 2 quarters · filed 2019-03-29
$420.00K
10-K · filed 2019-03-29
2017-09-30$64.00K
10-Q · filed 2018-11-14
$269.00K
10-Q · filed 2018-11-14